Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant |
| gptkbp:activeIngredient |
maprotiline
|
| gptkbp:approvedBy |
1974
|
| gptkbp:ATCCode |
N06AA21
|
| gptkbp:CASNumber |
10347-81-6
|
| gptkbp:chemicalFormula |
C20H23N
|
| gptkbp:developedBy |
gptkb:Ciba-Geigy
|
| gptkbp:drugClass |
antidepressant
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ludiomil
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:Europe |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
dizziness weight gain drowsiness dry mouth |
| gptkbp:soldIn |
gptkb:United_States
|
| gptkbp:synonym |
maprotiline hydrochloride
|
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:Maprotiline
|
| gptkbp:bfsLayer |
7
|